Systems LLC, a medical technology company, announced that the GammaPod stereotactic radiotherapy system has received CE marking, paving the way for new sales in Europe and offering patients the latest ...

Xcision Medical Systems, LLC has announced that the GammaPod Stereotactic Radiotherapy System, the world's first noninvasive external beam system optimized for partial breast treatments, has received ...

Baltimore, Md., Dec. 22, 2017 - The GammaPod ™ - a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer - has received 510(k) clearance from the U.S. Food and Drug ...

Xcision to Highlight Short, Noninvasive and Patient Friendly Treatment Option at ESTRO 38 in Milan, Italy from April 26-30 "We are excited to bring GammaPod to the European market, where the need for ...

Please provide your email address to receive an email when new articles are posted on . The FDA today granted clearance to GammaPod, a noninvasive stereotactic radiotherapy system, for treating cancer ...